Korsana Merger Deal Amendment Agreed
Cyclerion Therapeutics and Korsana Biosciences amended their merger agreement, modifying shareholder voting thresholds for stock issuance and articles of amendment. Korsana non-critically waived a specific approval requirement.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day